INS and Impaired glucose tolerance: Those findings render a nebivolol more appropriate therapy than atenolol for hypertensive patients suffering from metabolic syndrome or impaired glucose tolerance, potentially helping to stop the vicious cycle of hypertension, decreased insulin sensitivity, and hyperlipidemia (Rizos et al., 2003).